...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Incidence and sensitivity pattern of Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa in a tertiary care hospital
【24h】

Incidence and sensitivity pattern of Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa in a tertiary care hospital

机译:三级医院的肺炎克雷伯菌,大肠埃希菌和铜绿假单胞菌的发病率和敏感性模式

获取原文

摘要

Background: Antimicrobial resistance is a serious problem worldwide and differs from region to region. This study was planned to determine the incidence and sensitivity pattern of Klebsiella pneumoniae (K. pneumoniae) , Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) in our region and discuss the general issues related to antimicrobial resistance. Methods: Prospective study was carried out between March to October 2015. Samples of urine, blood, pus, CSF and miscellaneous samples (fluids, swabs, sputum and stool) were collected from indoor and outdoor patients for isolation and antimicrobial susceptibility of K. pneumoniae , E. coli and P. aeruginosa in the Department of Microbiology G.R. Medical College, Gwalior (MP). Results: Out of the 5000 samples analyzed 1684 showed growth. K. pneumoniae (38.50%), E. coli (33.29%) and P. aeruginosa (28.19%) constituited a total of 805 isolates. Both E.coli and K. pneumoniae showed highest sensitivity for doxycycline (75%; 67% resp.) and second highest for levofloxacin (70%; 64% resp.), whereas, P. aeruginosa showed highest 57% sensitivity for amikacin followed by 48% for levofloxacin. β-lactam antibiotics and aminoglycosides showed high mean resistance ( K.pneumoniae -83%, E.coli -79%, P. aeruginosa -86.4%) and ( K. pneumoniae -75%, E. coli -61%, P. aeruginosa -70%) resp. Conclusions: The data indicates high resistance among the gram-negative bacteria for β-lactam and aminoglycoside antibiotics. Increasing resistance to doxycycline and flouroquinolones for K. pneumoniae and E. coli and multidrug resistance to P. aeruginosa is a cause of concern in this region. Thus, there is a need to stop misuse of antibiotics with immediate effect and to implement a strong antimicrobial stewardship program.
机译:背景:抗菌素耐药性在全球范围内是一个严重的问题,并且因地区而异。计划进行这项研究,以确定我们地区的肺炎克雷伯菌,肺炎克雷伯菌,大肠埃希菌和铜绿假单胞菌(P. aeruginosa)的发病率和敏感性模式,并讨论与抗菌素耐药性有关的一般性问题。方法:于2015年3月至2015年10月进行前瞻性研究。从室内和室外患者收集尿液,血液,脓液,CSF和其他样本(液体,拭子,痰和粪便)样本,以分离和对肺炎克雷伯菌进行药敏试验。微生物系GR中的大肠杆菌,大肠杆菌和铜绿假单胞菌瓜廖尔医学院(MP)。结果:在分析的5000个样本中,有1684个显示出生长。肺炎克雷伯菌(38.50%),大肠杆菌(33.29%)和铜绿假单胞菌(28.19%)共构成805个分离株。大肠杆菌和肺炎克雷伯菌对多西环素的敏感性最高(分别为75%; 67%),对左氧氟沙星的敏感性最高(分别为70%; 64%),而铜绿假单胞菌对阿米卡星的敏感性最高,为57%。左氧氟沙星的使用率为48%。 β-内酰胺类抗生素和氨基糖苷类药物显示出较高的平均耐药性(肺炎克雷伯菌-83%,大肠杆菌-79%,铜绿假单胞菌-86.4%)和(肺炎克雷伯菌-75%,大肠杆菌-61%,P。铜绿-70%)resp。结论:数据表明革兰氏阴性菌对β-内酰胺和氨基糖苷类抗生素具有较高的耐药性。该地区对肺炎克雷伯菌和大肠杆菌对多西环素和氟喹诺酮类药物的耐药性增加以及对铜绿假单胞菌的多药耐药性引起了人们的关注。因此,需要立即停止滥用抗生素并实施强有力的抗菌素管理计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号